Clinical Trial Update: Impact of Intranasal Insulin on Sympathetic Activity and Cerebral Vasodilation [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial of intranasal insulin assessing sympathetic activity and cerebral vasodilation is currently suspended, sponsored by the University of Misso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autonomic Nervous System Disorders
• Insulin Resistance
• Obesity

Drugs mentioned

• Intranasal insulin (insulin)

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Healthy, Vasodilation | EARLY_Phase 1 | Status: SUSPENDED